[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Singapore

May 2012 | 25 pages | ID: M9D142E0E43EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
In 2011 medicated skin care fared better compared with 2010. Products such as Dettol experienced high value growth in 2011 due to strong brand loyalty and the perceived positive health benefits of these products. Antifungal products such as Daktarin also saw a significant increase in demand; the increased participation in sport in Singapore’s humid weather can be said to be a factor in this regard.

Euromonitor International's Medicated Skin Care in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN SINGAPORE

Euromonitor International
June 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Hoe Pharmaceuticals Sdn Bhd in Consumer Health (singapore)
Strategic Direction
Key Facts
  Summary 1 Hoe Pharmaceuticals Sdn Bhd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 2 Hoe Pharmaceuticals Sdn Bhd: Competitive Position 2011
Executive Summary
Strong Growth for Consumer Health
Paediatric Consumer Health Increases As the Birth Rate Increases
Race for Innovation in Order for Companies To Lead and Retain Market Share
Health and Beauty Retailers Stay As the Main Key Channels
Consumers Become More Astute About Product Information
Key Trends and Developments
Companies Build Brand Equity Through A High Rate of Innovation
Paediatric Consumer Health Grows Despite the Low Birth Rate
Internet Retailing Sees Steady Growth, Whilst Direct Selling Loses Share
Wellness Services Make A Dual Impact on Consumer Health
Increase in Physical Exercise and Nutrition Shape Demand for Consumer Health
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 3 OTC - Switches 2009-2011
Sources
  Summary 4 Research Sources


More Publications